▶ 調査レポート

世界のヨード造影剤(ICM)市場予測(~2028年):イオン性造影剤、非イオン性造影剤

• 英文タイトル:Global Iodinated Contrast Media (ICM) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のヨード造影剤(ICM)市場予測(~2028年):イオン性造影剤、非イオン性造影剤 / Global Iodinated Contrast Media (ICM) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028 / GIR-22F19435資料のイメージです。• レポートコード:GIR-22F19435
• 出版社/出版日:GlobalInfoResearch / 2022年11月
• レポート形態:英文、PDF、107ページ
• 納品方法:Eメール(2~3営業日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
「Global Iodinated Contrast Media (ICM) Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
グローバルインフォリサーチ社の最新の調査によると、世界のヨード造影剤(ICM)の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。

ヨード造影剤(ICM)市場はタイプ(種類)とアプリケーション(用途)によって区分されます。2017年~2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・イオン性造影剤、非イオン性造影剤

アプリケーション別セグメントは次のように区分されます。
・医用画像、疾患診断、その他

世界のヨード造影剤(ICM)市場の主要な市場プレーヤーは以下のとおりです。
・Bayer、GE Healthcare、Guerbet、Bracco、Fuji Pharma、Jiangsu Hengrui Medicine、Starry Pharmaceutical、Beilu Pharmaceutical、Yangzijiang Pharmaceutical Industry、Tyco International、Hexal AG、Sanochemia Pharmazeutika、Agfa Healthcare

地域別セグメントは次の地域・国をカバーします。
・北米市場(米国、カナダ、メキシコ)
・ヨーロッパ市場(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋市場(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南米市場(ブラジル、アルゼンチン、コロンビア)
・中東・アフリカ市場(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、ヨード造影剤(ICM)製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なヨード造影剤(ICM)メーカーの企業概要、2019年~2022年までのヨード造影剤(ICM)の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なヨード造影剤(ICM)メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年~2028年までの地域別ヨード造影剤(ICM)の販売量、売上、成長性を示しています。
・第5、6章では、2017年~2028年までのヨード造影剤(ICM)のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域でのヨード造影剤(ICM)市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびヨード造影剤(ICM)の産業チェーンを掲載しています。
・第13、14、15章では、ヨード造影剤(ICM)の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ヨード造影剤(ICM)の概要
- タイプ別分析(2017年vs2021年vs2028年):イオン性造影剤、非イオン性造影剤
- アプリケーション別分析(2017年vs2021年vs2028年):医用画像、疾患診断、その他
- 世界のヨード造影剤(ICM)市場規模・予測
- 世界のヨード造影剤(ICM)生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
- Bayer、GE Healthcare、Guerbet、Bracco、Fuji Pharma、Jiangsu Hengrui Medicine、Starry Pharmaceutical、Beilu Pharmaceutical、Yangzijiang Pharmaceutical Industry、Tyco International、Hexal AG、Sanochemia Pharmazeutika、Agfa Healthcare
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・タイプ別分析2017年-2028年:イオン性造影剤、非イオン性造影剤
・アプリケーション別分析2017年-2028年:医用画像、疾患診断、その他
・ヨード造影剤(ICM)の北米市場分析
- ヨード造影剤(ICM)の北米市場:タイプ別市場規模2017年-2028年
- ヨード造影剤(ICM)の北米市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:アメリカ、カナダ、メキシコなど
・ヨード造影剤(ICM)のヨーロッパ市場分析
- :ヨード造影剤(ICM)のヨーロッパ市場:タイプ別市場規模2017年-2028年
- :ヨード造影剤(ICM)のヨーロッパ市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・ヨード造影剤(ICM)のアジア太平洋市場分析
- ヨード造影剤(ICM)のアジア太平洋市場:タイプ別市場規模2017年-2028年
- ヨード造影剤(ICM)のアジア太平洋市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ヨード造影剤(ICM)の南米市場分析
- ヨード造影剤(ICM)の南米市場:タイプ別市場規模2017年-2028年
- ヨード造影剤(ICM)の南米市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:ブラジル、アルゼンチンなど
・ヨード造影剤(ICM)の中東・アフリカ市場分析
- ヨード造影剤(ICM)の中東・アフリカ市場:タイプ別市場規模2017年-2028年
- ヨード造影剤(ICM)の中東・アフリカ市場:アプリケーション別市場規模2017年-2028年
- 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Iodinated Contrast Media (ICM) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Iodinated Contrast Media (ICM) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Medical Imaging accounting for % of the Iodinated Contrast Media (ICM) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Ionic Contrast Media segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Iodinated Contrast Media (ICM) include Bayer, GE Healthcare, Guerbet, Bracco, and Fuji Pharma, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Iodinated Contrast Media (ICM) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Ionic Contrast Media
Non-ionic Contrast Media
Market segment by Application can be divided into
Medical Imaging
Disease Diagnosis
Others
The key market players for global Iodinated Contrast Media (ICM) market are listed below:
Bayer
GE Healthcare
Guerbet
Bracco
Fuji Pharma
Jiangsu Hengrui Medicine
Starry Pharmaceutical
Beilu Pharmaceutical
Yangzijiang Pharmaceutical Industry
Tyco International
Hexal AG
Sanochemia Pharmazeutika
Agfa Healthcare
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Iodinated Contrast Media (ICM) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Iodinated Contrast Media (ICM), with price, sales, revenue and global market share of Iodinated Contrast Media (ICM) from 2019 to 2022.
Chapter 3, the Iodinated Contrast Media (ICM) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Iodinated Contrast Media (ICM) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Iodinated Contrast Media (ICM) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Iodinated Contrast Media (ICM).
Chapter 13, 14, and 15, to describe Iodinated Contrast Media (ICM) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Iodinated Contrast Media (ICM) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Iodinated Contrast Media (ICM) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Ionic Contrast Media
1.2.3 Non-ionic Contrast Media
1.3 Market Analysis by Application
1.3.1 Overview: Global Iodinated Contrast Media (ICM) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Medical Imaging
1.3.3 Disease Diagnosis
1.3.4 Others
1.4 Global Iodinated Contrast Media (ICM) Market Size & Forecast
1.4.1 Global Iodinated Contrast Media (ICM) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Iodinated Contrast Media (ICM) Sales in Volume (2017-2028)
1.4.3 Global Iodinated Contrast Media (ICM) Price (2017-2028)
1.5 Global Iodinated Contrast Media (ICM) Production Capacity Analysis
1.5.1 Global Iodinated Contrast Media (ICM) Total Production Capacity (2017-2028)
1.5.2 Global Iodinated Contrast Media (ICM) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Iodinated Contrast Media (ICM) Market Drivers
1.6.2 Iodinated Contrast Media (ICM) Market Restraints
1.6.3 Iodinated Contrast Media (ICM) Trends Analysis
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Iodinated Contrast Media (ICM) Product and Services
2.1.4 Bayer Iodinated Contrast Media (ICM) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GE Healthcare
2.2.1 GE Healthcare Details
2.2.2 GE Healthcare Major Business
2.2.3 GE Healthcare Iodinated Contrast Media (ICM) Product and Services
2.2.4 GE Healthcare Iodinated Contrast Media (ICM) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Guerbet
2.3.1 Guerbet Details
2.3.2 Guerbet Major Business
2.3.3 Guerbet Iodinated Contrast Media (ICM) Product and Services
2.3.4 Guerbet Iodinated Contrast Media (ICM) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Bracco
2.4.1 Bracco Details
2.4.2 Bracco Major Business
2.4.3 Bracco Iodinated Contrast Media (ICM) Product and Services
2.4.4 Bracco Iodinated Contrast Media (ICM) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Fuji Pharma
2.5.1 Fuji Pharma Details
2.5.2 Fuji Pharma Major Business
2.5.3 Fuji Pharma Iodinated Contrast Media (ICM) Product and Services
2.5.4 Fuji Pharma Iodinated Contrast Media (ICM) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Jiangsu Hengrui Medicine
2.6.1 Jiangsu Hengrui Medicine Details
2.6.2 Jiangsu Hengrui Medicine Major Business
2.6.3 Jiangsu Hengrui Medicine Iodinated Contrast Media (ICM) Product and Services
2.6.4 Jiangsu Hengrui Medicine Iodinated Contrast Media (ICM) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Starry Pharmaceutical
2.7.1 Starry Pharmaceutical Details
2.7.2 Starry Pharmaceutical Major Business
2.7.3 Starry Pharmaceutical Iodinated Contrast Media (ICM) Product and Services
2.7.4 Starry Pharmaceutical Iodinated Contrast Media (ICM) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Beilu Pharmaceutical
2.8.1 Beilu Pharmaceutical Details
2.8.2 Beilu Pharmaceutical Major Business
2.8.3 Beilu Pharmaceutical Iodinated Contrast Media (ICM) Product and Services
2.8.4 Beilu Pharmaceutical Iodinated Contrast Media (ICM) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Yangzijiang Pharmaceutical Industry
2.9.1 Yangzijiang Pharmaceutical Industry Details
2.9.2 Yangzijiang Pharmaceutical Industry Major Business
2.9.3 Yangzijiang Pharmaceutical Industry Iodinated Contrast Media (ICM) Product and Services
2.9.4 Yangzijiang Pharmaceutical Industry Iodinated Contrast Media (ICM) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Tyco International
2.10.1 Tyco International Details
2.10.2 Tyco International Major Business
2.10.3 Tyco International Iodinated Contrast Media (ICM) Product and Services
2.10.4 Tyco International Iodinated Contrast Media (ICM) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Hexal AG
2.11.1 Hexal AG Details
2.11.2 Hexal AG Major Business
2.11.3 Hexal AG Iodinated Contrast Media (ICM) Product and Services
2.11.4 Hexal AG Iodinated Contrast Media (ICM) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Sanochemia Pharmazeutika
2.12.1 Sanochemia Pharmazeutika Details
2.12.2 Sanochemia Pharmazeutika Major Business
2.12.3 Sanochemia Pharmazeutika Iodinated Contrast Media (ICM) Product and Services
2.12.4 Sanochemia Pharmazeutika Iodinated Contrast Media (ICM) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Agfa Healthcare
2.13.1 Agfa Healthcare Details
2.13.2 Agfa Healthcare Major Business
2.13.3 Agfa Healthcare Iodinated Contrast Media (ICM) Product and Services
2.13.4 Agfa Healthcare Iodinated Contrast Media (ICM) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Iodinated Contrast Media (ICM) Breakdown Data by Manufacturer
3.1 Global Iodinated Contrast Media (ICM) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Iodinated Contrast Media (ICM) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Iodinated Contrast Media (ICM)
3.4 Market Concentration Rate
3.4.1 Top 3 Iodinated Contrast Media (ICM) Manufacturer Market Share in 2021
3.4.2 Top 6 Iodinated Contrast Media (ICM) Manufacturer Market Share in 2021
3.5 Global Iodinated Contrast Media (ICM) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Iodinated Contrast Media (ICM) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Iodinated Contrast Media (ICM) Market Size by Region
4.1.1 Global Iodinated Contrast Media (ICM) Sales in Volume by Region (2017-2028)
4.1.2 Global Iodinated Contrast Media (ICM) Revenue by Region (2017-2028)
4.2 North America Iodinated Contrast Media (ICM) Revenue (2017-2028)
4.3 Europe Iodinated Contrast Media (ICM) Revenue (2017-2028)
4.4 Asia-Pacific Iodinated Contrast Media (ICM) Revenue (2017-2028)
4.5 South America Iodinated Contrast Media (ICM) Revenue (2017-2028)
4.6 Middle East and Africa Iodinated Contrast Media (ICM) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Iodinated Contrast Media (ICM) Sales in Volume by Type (2017-2028)
5.2 Global Iodinated Contrast Media (ICM) Revenue by Type (2017-2028)
5.3 Global Iodinated Contrast Media (ICM) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Iodinated Contrast Media (ICM) Sales in Volume by Application (2017-2028)
6.2 Global Iodinated Contrast Media (ICM) Revenue by Application (2017-2028)
6.3 Global Iodinated Contrast Media (ICM) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Iodinated Contrast Media (ICM) Sales by Type (2017-2028)
7.2 North America Iodinated Contrast Media (ICM) Sales by Application (2017-2028)
7.3 North America Iodinated Contrast Media (ICM) Market Size by Country
7.3.1 North America Iodinated Contrast Media (ICM) Sales in Volume by Country (2017-2028)
7.3.2 North America Iodinated Contrast Media (ICM) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Iodinated Contrast Media (ICM) Sales by Type (2017-2028)
8.2 Europe Iodinated Contrast Media (ICM) Sales by Application (2017-2028)
8.3 Europe Iodinated Contrast Media (ICM) Market Size by Country
8.3.1 Europe Iodinated Contrast Media (ICM) Sales in Volume by Country (2017-2028)
8.3.2 Europe Iodinated Contrast Media (ICM) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Iodinated Contrast Media (ICM) Sales by Type (2017-2028)
9.2 Asia-Pacific Iodinated Contrast Media (ICM) Sales by Application (2017-2028)
9.3 Asia-Pacific Iodinated Contrast Media (ICM) Market Size by Region
9.3.1 Asia-Pacific Iodinated Contrast Media (ICM) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Iodinated Contrast Media (ICM) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Iodinated Contrast Media (ICM) Sales by Type (2017-2028)
10.2 South America Iodinated Contrast Media (ICM) Sales by Application (2017-2028)
10.3 South America Iodinated Contrast Media (ICM) Market Size by Country
10.3.1 South America Iodinated Contrast Media (ICM) Sales in Volume by Country (2017-2028)
10.3.2 South America Iodinated Contrast Media (ICM) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Iodinated Contrast Media (ICM) Sales by Type (2017-2028)
11.2 Middle East & Africa Iodinated Contrast Media (ICM) Sales by Application (2017-2028)
11.3 Middle East & Africa Iodinated Contrast Media (ICM) Market Size by Country
11.3.1 Middle East & Africa Iodinated Contrast Media (ICM) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Iodinated Contrast Media (ICM) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Iodinated Contrast Media (ICM) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Iodinated Contrast Media (ICM)
12.3 Iodinated Contrast Media (ICM) Production Process
12.4 Iodinated Contrast Media (ICM) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Iodinated Contrast Media (ICM) Typical Distributors
13.3 Iodinated Contrast Media (ICM) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer